SCHEMBL9946016

SCHEMBL9946016

CB(O)c1cc(C)ccc1OCC(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
MAPT P10636 2/20 0.47
THRB P10828 1/20 0.47
GPR55 Q9Y2T6 1/20 0.47
GAA P10253 1/20 0.42
NPSR1 Q6W5P4 1/20 0.40
ABCB1 P08183 2/20 0.37
ADRB2 P07550 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
USP2 O75604 1/20 0.36
HIF1A Q16665 1/20 0.36
XDH P47989 1/20 0.36
HTR1A P08908 1/20 0.35
PDE4B Q07343 2/20 0.35
PKM P14618 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM1A O60341 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12538847 0.90 ALDH1A1 (0.49) ALDH1A1MAPTTHRBGPR55GAA
SCHEMBL29955141 0.90 ALDH1A1 (0.49) ALDH1A1MAPTTHRBGPR55GAA
SCHEMBL2634947 0.80 ALDH1A1 (0.46) ALDH1A1MAPTTHRBGPR55GAA
SCHEMBL9946008 0.77 KDM4E (0.43) ALDH1A1MAPTTHRBGPR55GAA
SCHEMBL13607201 0.77 ALDH1A1 (0.61) ALDH1A1MAPTTHRBGPR55GAA
SCHEMBL2560927 0.76 TLR8 (0.40) ALDH1A1MAPTTHRBGPR55NPSR1
SCHEMBL3032643 0.75 ALDH1A1 (0.54) ALDH1A1MAPTTHRBGPR55GAA
SCHEMBL2560478 0.74 ESR1 (0.43) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL2558924 0.74 ABCB1 (0.38) ALDH1A1MAPTTHRBGPR55NPSR1
SCHEMBL2556340 0.73 HTR1A (0.46) ALDH1A1MAPTMEN1KMT2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149693-A1 THERAPEUTIC COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149693-A1 THERAPEUTIC COMPOUNDS HTR2C, GRK2, GRK3 ALDH1A1 4010/4885MAPT 2718/4885THRB 898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.